The accreditors of this session require that you periodically check in to verify that you are still attentive.
Please click the button below to indicate that you are.
"What's New with Reimbursement and Coding for Blood Products, Transfusion Medicine and Cellular Therapies?" will provide attendees with an update on billing requirements and reimbursement policies that impact blood products, transfusion medicine and cellular therapies. In addition, speakers will discuss AABB's activities related to coding and reimbursement. Session attendees will have the opportunity to have their coding and billing questions answered by the experts.
Learning Objectives:
Describe updates to relevant Medicare policies impacting reimbursement for blood and transfusion medicine.
Describe updates to payment policies for cellular therapies.
Describe recent advocacy initiatives aimed at ensuring appropriate Medicare reimbursement for blood, transfusion medicine and cellular therapies.
Speaker(s):
Dr. Mary
Berg,
MD,
Professor of Clinical Practice, Pathology Medical Director, Transfusion Services,
University of Colorado
You must be logged in and own this session in order to
post comments.
How to Claim CE Credit
Complete the evaluation found on the "CE Information" tab after watching the video. By submitting the evaluation, you are attesting to watching the presentation in its entirety.
